MunnWorks, Applied UV’s Subsidiary, Enhances Dollywood’s HeartSong Lodge & Resort With Lighted & Decorative Mirrors, and Custom Vanities

2 years ago

Applied UV, Inc. MunnWorks Vanity and Mirror NEW YORK, NY, Nov. 20, 2023 (GLOBE NEWSWIRE) -- via NewMediaWire -- Applied…

PMcardio Is The First Certified Solution To Outperform Doctors in Heart Attack Detection With AI

2 years ago

PMcardio Queen of Hearts PMcardio's Queen of Hearts AI model is the first certified solution to outperform doctors in heart…

HOOKIPA Pharma Announces FDA Clearance of its Investigational New Drug Application for HB-500 for the Treatment of Human Immunodeficiency Virus

2 years ago

Novel arenaviral therapeutic vaccine, developed in collaboration with Gilead Sciences, Inc. (‘Gilead’), to be evaluated as a potential curative regimen…

Fortrea Announces AI-Driven Partnership with Medidata to Increase Diversity in Clinical Trials

2 years ago

Collaboration leverages Medidata AI to improve access and participation of diverse population groups in clinical studiesDURHAM, N.C., Nov. 20, 2023…

NextCure to Present at the 35th Annual Piper Sandler Healthcare Conference

2 years ago

BELTSVILLE, Md., Nov. 20, 2023 (GLOBE NEWSWIRE) -- NextCure, Inc. (Nasdaq: NXTC), a clinical-stage biopharmaceutical company committed to discovering and…

C4 Therapeutics Strengthens Board of Directors with Owen Hughes Appointment

2 years ago

Owen Hughes, Accomplished Life Sciences Executive with Deep Experience Across Investing, Operations and Governance, Appointed as Independent Member of the…

Agios Announces Clinical Proof-of-Concept in Phase 2a Trial of AG-946 for the Treatment of Anemia in Lower-Risk Myelodysplastic Syndromes

2 years ago

– 40 Percent of Low Transfusion Burden Cohort Achieved Transfusion Independence;One Study Patient Achieved Hemoglobin Response Endpoint – – Safety…

IN8bio’s INB-200 Demonstrates Extended Progression-Free Survival in Patients with Newly Diagnosed Glioblastoma

2 years ago

All patients treated with INB-200 who completed mandated doses to date have exceeded a progression-free survival (PFS) of seven months…

Gritstone bio to Participate in Upcoming Investor Conferences

2 years ago

EMERYVILLE, Calif., Nov. 20, 2023 (GLOBE NEWSWIRE) -- Gritstone bio, Inc. (Nasdaq: GRTS), a clinical-stage biotechnology company working to develop…